Skip to main content
Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses

Fig. 1

The effects of ALX on the survival and proliferation of BMDC. On day 7 of culture, BMDC (n = 6) were treated with or without ALX at the indicated dose for 12 h. Some DCs were further stimulated with LPS (1 μg/ml) for 48 h. The percentages of apoptotic in different groups of BMDCs were determined by flow cytometry analysis. The survival and LPS-stimulated proliferation of BMDCs were assessed by CCK-8 assays. a Flow cytometry analysis of apoptotic cells. b Survival of BMDCs from each group. c Proliferation of LPS-stimulated BMDCs from different groups. ※p < 0.05, *p < 0.01, #p < 0.001, NS means no statistical difference vs. the cells treated with LPS alone

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094